Evidence map›Paper›PMID 17089071›Full record

ArticleJournal of human genetics2007

MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.

Mei-Rong Li, Hong Pan, Xin-Hua Bao, Yu-Zhi Zhang, Xi-Ru Wu

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 47 citations in OpenAlex.

  1. Identification of aFrontiers in molecular neuroscience · 2022
    Article
  2. Article
  3. Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.Journal of autism and developmental disorders · 2020
    Article
  4. Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.Autism research : official journal of the International Society for Autism Research · 2012
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mei-Rong LiDepartment of Pediatrics, Peking University First Hospital, No.1 of Xi An Men Street, Xi Cheng District, Beijing, 100034, People's Republic of China.
Hong PanDepartment of Pediatrics, Peking University First Hospital, No.1 of Xi An Men Street, Xi Cheng District, Beijing, 100034, People's Republic of China. panmuren@yahoo.com.
Xin-Hua BaoDepartment of Pediatrics, Peking University First Hospital, No.1 of Xi An Men Street, Xi Cheng District, Beijing, 100034, People's Republic of China.
Yu-Zhi ZhangDepartment of Pediatrics, Peking University First Hospital, No.1 of Xi An Men Street, Xi Cheng District, Beijing, 100034, People's Republic of China.
Xi-Ru WuDepartment of Pediatrics, Peking University First Hospital, No.1 of Xi An Men Street, Xi Cheng District, Beijing, 100034, People's Republic of China.
Peking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rett syndrome (RTT) is a progressive neurodevelopmental disorder that is caused by mutations in the X-linked methyl-CpG-binding protein2 (MECP2) gene. In this study, the MECP2 sequences in 121 unrelated Chinese patients with classical or atypical RTT were screened for deletions and mutations. In all, we identified 45 different MECP2 mutations in 102 of these RTT patients. The p. T158M mutation (15.7%) was the most common, followed in order of frequency by p. R168X (11.8%), p. R133C (6.9%), p. R270X (6.9%), p. G269fs (6.9%), p. R255X (4.9%), and p. R306C (3.9%). In addition, we identified five novel MECP2 mutations: three missense (p. K305E, p. V122M, p. A358T), one insertion (c.45-46insGGAGGA), and one 22 bp deletion (c.881-902del22). Large deletions represented 10.5% of all identified MECP2 mutations. Conversely, mutations in exon 1 appeared to be rare (0.9%). The remaining cases without MECP2 mutations were screened for the cyclin-dependent kinase-like 5 (CDKL5) gene using denaturing high-performance liquid chromatography (DHPLC). One synonymous mutation (p. I72I) was found in exon 5, suggesting that CDKL5 is a rare cause of RTT. The overall MECP2 mutation detection rate for this patient series was 84.3:87.9% in 107 classical RTT cases and 57.1% in 14 atypical RTT cases. Moreover, there were two patients with homozygous mutations and normal female karyotypes. However, we did not pinpoint a significant relationship between genotype and phenotype in these cases.

Indexed as

AdolescentAdultBase SequenceChildChromatography, High Pressure LiquidDNA Mutational AnalysisExonsFemaleGene DeletionHumansMethyl-CpG-Binding Protein 2Molecular Sequence DataMutationProtein Serine-Threonine KinasesRett SyndromeCDKL5 protein, humanMECP2 protein, humanMethyl-CpG-Binding Protein 2Protein Serine-Threonine Kinases

Identifiers

PMID17089071
OpenAlexW2150717926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.